Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
7.84
+0.16 (2.08%)
Aug 18, 2026, 1:03 PM EDT - Market open
CPIX Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 44.3 | 44.52 | 37.87 | 39.55 | 42.01 | 35.99 |
Revenue Growth | 120.76% | 17.57% | -4.26% | -5.85% | 16.75% | -3.89% |
Gross Profit Gross Profit Growth | 37.64 | 37.85 | 31.28 | 33.49 | 32.89 | 27.17 |
Operating Income Operating Income Growth | -3.04 | -2.79 | -6.43 | -6.21 | -5.7 | -7.68 |
Net Income Net Income Growth | -10.92 | -2.84 | -6.48 | -6.28 | -5.57 | -3.51 |
Earnings Per Share EPS Growth | -0.74 | -0.19 | -0.46 | -0.44 | -0.38 | -0.24 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 39.62 | 35.17 | 38.45 | 40.51 | 33.79 |
China China Growth | 2.98 | - | - | - | - |
South Korea South Korea Growth | 1.32 | 1.49 | - | - | - |
Russia Russia Growth | 0.43 | 0.47 | - | - | - |
Mexico Mexico Growth | 0.12 | 0.01 | - | - | - |
Australia Australia Growth | 0.03 | 0.05 | - | - | - |
Saudi Arabia Saudi Arabia Growth | 0.01 | 0.65 | - | - | - |
Other Outside The United States Other Outside The United States Growth | 0.01 | 0.04 | - | - | - |
Total Total Growth | 44.52 | 37.87 | 39.55 | 42.01 | 35.99 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3.86 | 11.44 | 17.96 | 18.32 | 19.76 | 27.04 |
Total Debt Total Debt Growth | 4.71 | 10.18 | 20.57 | 18.43 | 20.96 | 16.06 |
Net Cash (Debt) Net Cash Growth | -0.85 | 1.26 | -2.61 | -0.11 | -1.2 | 10.98 |
Net Cash Growth | - | - | - | - | - | 43.03% |
Net Cash Per Share Net Cash Per Share Growth | -0.06 | 0.09 | -0.19 | -0.01 | -0.08 | 0.74 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 0.75 | 4.93 | -0.61 | 6.09 | 8.45 | 6.34 |
Capital Expenditures CapEx Growth | -0.06 | -0.1 | -0.07 | -0.28 | -0.1 | -0.1 |
Free Cash Flow Free Cash Flow Growth | 0.68 | 4.83 | -0.68 | 5.81 | 8.35 | 6.24 |
Free Cash Flow Growth | -90.27% | - | - | -30.40% | 33.86% | 18.29% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 84.95% | 85.02% | 82.61% | 84.66% | 78.30% | 75.51% |
Operating Margin | -6.87% | -6.27% | -16.99% | -15.70% | -13.58% | -21.34% |
Pretax Margin | -7.19% | -6.34% | -17.08% | -15.89% | -13.29% | -15.46% |
Profit Margin | -24.64% | -6.37% | -17.11% | -15.88% | -13.26% | -9.75% |
FCF Margin | 1.54% | 10.86% | -1.79% | 14.70% | 19.88% | 17.34% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
P/FCF Ratio | 165.41 | 12.31 | - | 4.59 | 3.90 | 11.04 |
PS Ratio | 2.55 | 1.34 | 0.88 | 0.68 | 0.78 | 1.92 |